🇺🇸 FDA
Pipeline program

METFORMIN , The placebo components are propylene glycol, neoPCLO/W, fenonip XB and purified water., METHYL AMINOLEVULINATE

ICI21/00031

Phase 2 small_molecule active

Quick answer

METFORMIN , The placebo components are propylene glycol, neoPCLO/W, fenonip XB and purified water., METHYL AMINOLEVULINATE for Actinic keratoses is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Actinic keratoses
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials